Dadachanji Group launches KAISHA Pharma with €45 million investment
New Delhi, Sept. 4 -- Dadachanji Group has launched KAISHA Pharma, a new global pharmaceutical packaging company, with an initial investment of €45 million as part of a substantial multi-million-euro commitment towards infrastructure, manufacturing capacity and operational capabilities.
KAISHA Pharma builds on the Dadachanji Group's 35-year legacy in pharmaceutical glass packaging and will serve pharmaceutical and biotechnology companies in India and global markets.
The company will offer a complete range of tubular glass packaging products, including ampoules, vials, prefilled syringes and cartridges, along with Ready-to-Use (RTU) platforms for vials, prefilled syringes and cartridges.
KAISHA Pharma said its solutions are design...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.